NASDAQ:CGEM | Cash Flow Statement | Cullinan Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$53.7M
2026-03-31-$49.66M$79,000.00-$46.05M$32.41M$380,000.00
2025-12-31-$50.71M$79,000.00-$38.11M$11,000.00$22.39M$715,000.00
2025-09-30-$50.61M
2025-06-30-$70.06M
2025-03-31-$48.5M$76,000.00-$43.16M$36.81M$0.00
2024-12-31-$47.65M$77,000.00-$36.63M$0.00$15.96M$1.58M
2024-09-30-$40.56M
2024-06-30-$42.03M
2024-03-31-$37.15M$76,000.00-$38.25M$0.00$12.96M$1.09M
2023-12-31-$23.8M$77,000.00-$18.13M$0.00$51.47M$248,000.00
2023-09-30-$39.18M
2023-06-30-$32.21M
2023-03-31-$57.96M$72,000.00-$51M$159,000.00$15.18M$1.79M
2022-12-31-$26.78M$59,000.00-$24.98M$882,000.00-$28.61M-$32.91M
2022-09-30-$24.8M
2022-06-30$174.9M
2022-03-31-$12.1M$13,000.00-$21.91M$0.00$34.71M$3.54M
2021-12-31-$32.51M$12,000.00-$15.17M$0.00-$15.86M$2.7M
2021-09-30-$17.35M
2021-06-30-$15.64M
2021-03-31-$70,000.00$15,000.00-$1.52M-$137.73M$264.58M
2020-12-31-$28.35M$15,000.00-$9.44M-$1,000.00$11.44M$6.36M$124.9M
2020-09-30-$9.86M
2020-06-30-$8.62M
2020-03-31-$4.97M$16,000.00-$5.02M$3,000.00-$26.89M$213,000.00$14.04M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$219.88M$311,000.00-$175.75M$49,000.00$179.99M$1.09M
2024-12-31-$167.38M$306,000.00-$145.3M$0.00-$136.31M$266.19M
2023-12-31-$153.16M$310,000.00-$134.28M$208,000.00$35.81M$40.75M
2022-12-31$111.21M$93,000.00-$126.66M$1.13M$248.98M-$25.93M
2021-12-31-$65.57M$53,000.00-$43.43M$0.00-$333.78M$268.78M
2020-12-31-$51.8M$62,000.00-$29.77M$10,000.00-$5.42M$6.57M$140.14M